Skip to main content
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2022 Apr 5;26(7):2137. doi: 10.1111/jcmm.17270

 

PMCID: PMC8980972  PMID: 35384286

In Ting Zhu et al, 1 the images of A549‐Vector (Migration, left panel) group and A549‐shRNA1 (Migration) group in Figure 2B contain errors. The correct figure is shown below. The authors confirm all results and conclusions of this article remain unchanged.

FIGURE 2.

FIGURE 2

DUXAP9‐206 promotes NSCLC cell proliferation and invasion in vitro. (A) Representative micrographs of wound closures at 0 and 24 h after wounding. (B) The indicated invading or migrating cells analysed by Matrigel‐coated or noncoated Transwell assays, respectively. (C) Quantification of the indicated invading or migrating cells in 5 random fields analysed by Transwell assays. *p < 0.05. (D) MTT assays were performed in the indicated cells. (E) Representative micrographs (left panel) and quantification (right panel) of colony formation. *p < 0.05

REFERENCE

  • 1. Zhu T, An S, Choy MT, et al. LncRNA DUXAP9‐206 directly binds with Cbl‐b to augment EGFR signaling and promotes non‐small cell lung cancer progression. J Cell Mol Med. 2019;23:1852‐1864. doi: 10.1111/jcmm.14085 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES